Clinical trial · no report yet · Phase 2

NRG-BN001 trial: what clinicians have said so far

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

NCT02179086 ↗
Active, not recruiting
NRG Oncology
Focused size, estimated: 1–150 verified statements once built

We haven't built an HCP commentary report on NRG-BN001 (newly diagnosed glioblastoma; tests a strategy, not a drug) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.

Indexed commentary on NRG-BN001 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

Indexed so far
7 posts on X, typically up to 31 once built
2 YouTube videos, typically up to 9 once built
1 podcast episode, typically up to 4 once built

Indexed todayTypical once built

The trial

ClinicalTrials.gov

Official title: Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Phase: Phase 2
Status: Active, not recruiting
Conditions: Glioblastoma
Interventions: Photon Beam Radiation Therapy; Proton Beam Radiation Therapy; Temozolomide
Arms: Group 1 - Standard RT (Photon) (Arm A1) · Active comparator
Group 2 - Standard RT (Proton) (Arm A2) · Active comparator
Group 1 - Intensified RT (Photon) (Arm B) · Experimental
Group 2 - Intensified RT (Proton) (Arm C) · Experimental
Enrollment: 624
Primary outcomes: Median Survival Time (Within Center Group)
Sponsor: NRG Oncology with National Cancer Institute (NCI)
Start: Dec 4, 2014
Primary completion: Jul 7, 2025
Results posted: Yes
Registry record: NCT02179086 · updated Oct 1, 2026

Get this report

Focused

Report, built on orderBuilt within 24 hours of confirming your order: $750

Order this report

Quoted on an estimate of the verified statements in the commentary we've indexed so far. Final coverage is set when we build it.You never pay more than quoted: if the report is delivered at a smaller size, you pay that size's price, and anything paid above it is refunded.We build it within 24 hours of confirming your order. If we can't build it to our standard, you aren't charged.

Request a free preview

Ask us to build this report. Once it's built, its free preview (summary, finding titles and coverage) is published on this page and we email you the link. The full report is sold separately. Use your work email; we'll send a link to confirm it.

For agents: .json · .md